TARS Latest Press Releases

-- April 29, 2026 --

Tarsus to Report First Quarter 2026 Financial Results on Wednesday, May 6, 2026 Globe Newswire 4:30 PM

-- March 31, 2026 --

Tarsus Doses First Participant in Calliope, A Phase 2 Clinical Trial of TP-05 (lotilaner), a Novel Investigational Oral Tablet for the Potential Prevention of Lyme Disease Globe Newswire 8:30 AM

-- March 23, 2026 --

TP-03 (lotilaner ophthalmic solution) 0.25% Now Approved in China for the Treatment of Demodex Blepharitis, Triggering a $15M Milestone Payment to Tarsus Globe Newswire 8:30 AM

-- February 26, 2026 --

Tarsus to Participate in Upcoming Investor Conferences Globe Newswire 4:30 PM

-- February 23, 2026 --

Tarsus Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Achievements Globe Newswire 4:05 PM

-- February 18, 2026 --

Tarsus Pharmaceuticals Appoints Renowned Biopharmaceutical Leader and Former Allergan CEO, David Pyott, to its Board of Directors Globe Newswire 8:30 AM

-- February 17, 2026 --

Tarsus to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, February 23, 2026 Globe Newswire 4:30 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software